← back to search

Brandon Young

University of Southern California · US
Area of research
Cancer Research · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Radiomics and Machine Learning in Medical Imaging, Protein Degradation and Inhibitors, Breast Cancer Treatment Studies, and Cancer Genomics and Diagnostics.
h-index
31
citations
3,602
works
137
NIH funding
primary concept
email

Recent publications

Targeting KDM4 for treating PAX3-FOXO1–driven alveolar rhabdomyosarcoma
Science Translational Medicine 2022cited by 38position: middledoi
A <scp>WIN</scp> Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non‐small cell lung cancer
Cancer Medicine 2022cited by 25position: middledoi
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab
JAMA Oncology 2016cited by 99position: middledoi
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial
Breast Cancer Research and Treatment 2015cited by 34position: middledoi
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer
Breast Cancer Research and Treatment 2015cited by 20position: middledoi
Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner
PLoS ONE 2013cited by 78position: middledoi

Grants

SBIR Phase II: Material Adjusted Signature Tags for Cradle-to-Grave Inventory Applications
NSF2136796$1,731,9992022–2026PIRePORTER
SBIR Phase I: Universal Chip-less Identification of Inventory Using Antennas Tuned to Existing Networks
NSF1940248$224,5552019–2021PIRePORTER

Frequent collaborators

Brian Leyland‐Jones · Avera Health4 papers (2015–2022)Giuseppe Viale · European School of Oncology3 papers (2015–2016)Mark Bouzyk · Northwood University3 papers (2013–2015)Bradley Long · Embedded Systems (United States)3 papers (2015–2016)Mark Abramovitz · McGill University Health Centre3 papers (2013–2015)Karen N. Price · Smiths Detection (Canada)2 papers (2015–2015)Vernon Harvey · University of Auckland2 papers (2015–2015)Aron Goldhirsch · Harvard University2 papers (2015–2015)Kathryn P. Gray · Novartis (Switzerland)2 papers (2015–2015)Patrick Neven · European Organisation for Research and Treatment of Cancer2 papers (2015–2015)Meredith M. Regan · Harvard University2 papers (2015–2015)Rudolf Maibach · Foundation Medical Partners2 papers (2015–2015)Roswitha Kammler · Tecnológico de Monterrey2 papers (2015–2015)James M. Rae · University of Michigan2 papers (2015–2015)Patrizia Dell’Orto · European School of Oncology2 papers (2015–2015)Beat Thürlimann · Sonnenhalde (Switzerland)2 papers (2015–2015)Olivia Pagani · Hôpital Riviera-Chablais2 papers (2015–2015)Maria Olivia Biasi · European Institute of Oncology2 papers (2015–2015)Alan S. Coates · The University of Sydney2 papers (2015–2015)Enriqueta Felip · Université Grenoble Alpes1 papers (2022–2022)